AG NPP709 is now on the market; nevertheless, no study has investigated the influence of AG NPP709 in patients with COPD. Thus, the goal of the study was to evaluate the efficacy of AG NPP709 in people with Persistent bronchitis form COPD. Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor https://benjaming196wfo3.blog-ezine.com/profile